As shown in Figures 7C and 7D, all of the mice that received CT3 CAR T cells showed complete and sustained tumor regression; in other words, the tumor burden was undetectable by BLI over 5 weeks post-infusion. This evidence concerns the gene CAGE1 and neoplasm.